3954 Showa Paxxs

Watchlist

1775
-24-1.33%

20min DelayMarket Closed Dec 17 15:30 JST

7.90BMarket Cap8.19P/E (Static)

Showa Paxxs Key Stats

According to the latest financial report of Showa Paxxs, the latest earnings per share (TTM) for the company is 102.10. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: JPY

Quarterly

FCF

Interested in knowing about Showa Paxxs's free cash flow? The latest report shows it as -432.26M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Showa Paxxs shows that the company's current ratio is 2.66, indicating healthy liquidity.

Currency: JPY

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Showa Paxxs, the quick ratio is 2.14, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

ROE

Want to learn more about the financial health of Showa Paxxs? The latest ROE figure is 1.23%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Showa Paxxs, the total asset return on investment (ROA) is 0.85%.

Currency: JPY

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Showa Paxxs's latest financial report to see how their gross margin is doing - currently at 17.47%.

Currency: JPY

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Showa Paxxs, the net profit margin is 9.02%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Top JP Stock Gainers

Symbol Price % Chg

D. Western Therapeutics Institute